Abstract
Introduction
Pregnancy and lactation-associated osteoporosis (PLO) is an uncommon condition characterized by the occurrence of fracture(s) during late pregnancy or the puerperium. The aetiology is uncertain, and its management and natural history poorly defined.
Methods
We report a series of 11 women with PLO seen at our institution over the past 20 years, with follow-up ranging from 1 to 19 years.
Results
Ten women presented with painful low-trauma vertebral fractures, at a median of 1 month postpartum. In nine cases the fractures were multiple (median: 3, range: 2–5). At least one recognised risk factor for osteoporosis (low body weight, smoking history, family history of osteoporosis/fracture, vitamin D insufficiency) was present in nine patients. Bone density was in the osteoporotic range at the spine (mean T score: −2.8), with less marked reduction at the proximal femur (mean T score: −1.9). Nine patients received bisphosphonate treatment, for a median duration of 24 months. In the five women who received a bisphosphonate within 1 year of presentation, spinal bone density increased by 23% over baseline values after 2 years of treatment (p=0.0014). Of the 5 women who had subsequent pregnancies, one, who had declined bisphosphonate therapy after the initial presentation, sustained a fracture in the postpartum period. Two patients (both of whom were followed for at least 10 years) sustained fractures outside of pregnancy.
Conclusions
PLO is therefore associated with significant morbidity, a high prevalence of recognized risk factors for osteoporosis and a risk of recurrence in subsequent pregnancies. Bisphosphonate therapy administered soon after presentation substantially increases spinal bone density in patients with PLO.
Similar content being viewed by others
References
VanHouten JN, Wysolmerski JJ (2003) Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice. Endocrinology 144:5521–5529
Reid IR, Wattie DJ, Evans MC, Budayr AA (1992) Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol (Oxf) 37:298–303
Sowers MF, Hollis BW, Shapiro B et al (1996) Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276:549–554
Khovidhunkit W, Epstein S (1996) Osteoporosis in pregnancy. Osteoporos Int 6:345–354
Carbone LD, Palmieri GM, Graves SC, Smull K (1995) Osteoporosis of pregnancy: long-term follow-up of patients and their offspring. Obstet Gynecol 86:664–666
Burrows HJ, Graham G (1945) Spinal osteoporosis of unknown origin. Q J Med 14:147–169
Albright F, Reifenstein EC (1948) The parathyroid glands and metabolic bone disease. Williams and Wilkins, Baltimore
Jones OV (1953) Crush fracture of the dorsal spine in eclampsia. J Obstet Gynaecol Br Commonw 60:259–262
Nordin BEC, Roper A (1955) Post-pregnancy osteoporosis. Lancet 268:431–434
Jackson WP (1958) Osteoporosis of unknown cause in younger people: idiopathic osteoporosis. J Bone Joint Surg Br 40:420–441
Hall JW, Kennedy BJ (1961) Idiopathic osteoporosis. Arch Intern Med 108:448–455
Dent CE, Friedman M (1965) Pregnancy and idiopathic osteoporosis. Q J Med 34:341–357
Gruber HE, Gutteridge DH, Baylink DJ (1984) Osteoporosis associated with pregnancy and lactation: bone biopsy and skeletal features in three patients. Metab Bone Dis Relat Res 5:159–165
Smith R, Athanasou NA, Ostlere SJ, Vipond SE (1995) Pregnancy-associated osteoporosis. QJM 88:865–878
Lam SY, Evans JH, Quinn MA, Baker HW (1987) Postpartum spinal wedge fractures in a 27-year-old epileptic anorectic woman. Aust N Z J Obstet Gynaecol 27:71–74
Kinsella P, O’Brien T, Brosnan E, O’Sullivan DJ (1991) A case of pregnancy associated osteoporosis and empty sella syndrome. Ir Med J 84:25–26
Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39:487–490
Yamamoto N, Takahashi HE, Tanizawa T, Kawashima T, Endo N (1994) Bone mineral density and bone histomorphometric assessments of postpregnancy osteoporosis: a report of five patients. Calcif Tissue Int 54:20–25
Khan AA, Ahmed MM, Pritzker KPH (1995) Osteoporosis associated with pregnancy: case report and review. Endocr Pract 1:236–238
Breuil V, Brocq O, Euller-Ziegler L, Grimaud A (1997) Insufficiency fracture of the sacrum revealing a pregnancy associated osteoporosis. First case report. Ann Rheum Dis 56:278–279
Vandecandelaere M, Cortet B, Flipo RM, Duquesnoy B, Delcambre B (1997) Osteoporosis in pregnancy: apropos of 2 cases. Rev Med Interne 18:571–574
Liel Y, Atar D, Ohana N (1998) Pregnancy-associated osteoporosis: preliminary densitometric evidence of extremely rapid recovery of bone mineral density. South Med J 91:33–35
Schmid L, Pfirrmann C, Hess T, Schlumpf U (1999) Bilateral fracture of the sacrum associated with pregnancy: a case report. Osteoporos Int 10:91–93
Di Gregorio S, Danilowicz K, Rubin Z, Mautalen C (2000) Osteoporosis with vertebral fractures associated with pregnancy and lactation. Nutrition 16:1052–1055
Anai T, Tomiyasu T, Arima K, Miyakawa I (1999) Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res 25:63–67
Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 11:449–454
Jensen JE, Mortensen G (2000) Graviditetsinduceret osteoporose. Ugeskr Laeger 162:3865–3866
Clemetson IA, Popp A, Lippuner K, Ballmer F, Anderson SE (2004) Postpartum osteoporosis associated with proximal tibial stress fracture. Skeletal Radiol 33:96–98
Baszko-Blaszyk D, Horst-Sikorska W, Sowinski J (2005) Pregnancy-associated osteoporosis manifesting for the first time during second pregnancy. Ginekol Pol 76:67–69
Blanch J, Pacifici R, Chines A (1994) Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol 33:269–272
Sarikaya S, Ozdolap S, Acikgoz G, Erdem CZ (2004) Pregnancy-associated osteoporosis with vertebral fractures and scoliosis. Joint Bone Spine 71:84–85
Sowers M (1996) Pregnancy and lactation are risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 15:557–563
Moya F, Peris P, Guanabens N et al (1993) Osteoporosis associated with pregnancy. Description of 3 cases. Med Clin (Barc) 100:743–745
Parnell W, Wilson N, Faed J et al (1999) NZ food, NZ people: key results of the 1997 National Nutrition Survey. Ministry of Health, Wellington
Cranney A, Tugwell P, Adachi J et al (2002) Meta-analyses of therapies for post-menopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:517–523
Cranney A, Wells G, Willan A et al (2002) Meta-analyses of therapies for post-menopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:508–516
Ott SM (2005) Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90:1897–1899
Acknowledgements
This work was supported by grants from the Australian and New Zealand Bone and Mineral Society (Dr. O’Sullivan) and by the Health Research Council of New Zealand.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
O’Sullivan, S.M., Grey, A.B., Singh, R. et al. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17, 1008–1012 (2006). https://doi.org/10.1007/s00198-006-0112-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-006-0112-3